This study will investigate usability and compliance related to rhinix nasal filters for the treatment of seasonal allergic rhinitis (hay fever) during the natural grass pollen season in Denmark.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
1,073
Aarhus University, School of Public Health, Department of Environmental & Occupational Medicine
Aarhus, Denmark
Week 1 likelihood of continued use of RHINIX after study end.
In week 1: The proportion of subjects that rate that they will definitely or are likely to continue using RHINIX after the study is over given that they have stated that they have tried the device.
Time frame: 1 assessment at the end of the 1st week of use.
Week 2 likelihood of continued use of RHINIX after study end.
In week 2: The proportion of subjects that rate that they will definitely or are likely to continue using RHINIX after the study is over given that they have stated that they have tried the device.
Time frame: 1 assessment at the end of the 2nd week of use.
Week 1 Satisfaction with RHINIX
In week 1: The proportion of subjects who are completely or somewhat satisfied with RHINIX given that they have used the product.
Time frame: 1 assessment at the end of the 1st week
Week 2 satisfaction with RHINIX
In week 2: The proportion of subjects who are completely or somewhat satisfied with RHINIX given that they have used the product.
Time frame: One assessment at the end of the 2nd week
Week 1: RHINIX Control
In week 1: The proportion of subjects who state that RHINIX has helped "to a very high degree" or "to a high degree" in controlling their hay fever symptoms given that they have used the product
Time frame: One assessment at the end of the 1st week of use
Week 2: RHINIX Control
In week 2: The proportion of subjects who state that RHINIX has helped "to a very high degree" or "to a high degree" in controlling their hay fever symptoms given that they have used the product
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: One assessment at the end of the 2nd week of use.